Surveillance for Adverse Events Following Influenza Immunization
Active Surveillance of Adverse Events Following Immunization Among Healthcare Workers Immunized With the Influenza Vaccine
Sponsor: CHU de Quebec-Universite Laval
A observational or N/A phase clinical study on Influenza and Vaccines Adverse Reaction, this trial is completed. The trial is conducted by CHU de Quebec-Universite Laval and has accumulated 8 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Jul 2017 [monthly]
Completed NA
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CHU de Quebec-Universite Laval
- Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- GlaxoSmithKline
- IWK Health Centre
- Institut National en Santé Publique du Québec
- Laval University
- Mount Sinai Hospital, Canada
- PHAC/CIHR Influenza Research Network
- The Ottawa Hospital
- University of British Columbia
For direct contact, visit the study record on ClinicalTrials.gov .